EVP, Chief Scientific Officer Bennett C Frank sold $1,744,623 worth of shares (20,536 units at $84.95) as part of a pre-agreed trading plan and acquired 15,000 shares as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 75,018 units (SEC Form 4)